Tag: Health

news-27112024-115756

Jim O’Neill Named HHS Deputy Secretary by Trump: Biotech Investor

President-elect Trump has selected biotech investor Jim O'Neill as the nominee for deputy secretary of the Health and Human Services department. If confirmed, O'Neill...
news-27112024-055630

Jay Bhattacharya: Trump’s Choice to Lead NIH

President-elect Trump has made his selection for the role of leading the National Institutes of Health known, with Stanford University professor Jay Bhattacharya being...
news-26112024-115233

Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions

Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a...
news-26112024-054957

Title: Analysis of Alector Therapeutics’ Alzheimer’s Treatment Failure in Phase 2 Study

Alector Therapeutics announced that their Phase 2 trial for a potential Alzheimer's antibody, known as AL002, was unsuccessful. This setback is disappointing as the...
news-25112024-234610

The End of Cassava Sciences and its Alzheimer’s Drug: Lingering Damage

The story of Cassava Sciences came to a disappointing end on Monday when their experimental drug for Alzheimer's disease, simufilam, was found to be...
news-22112024-142640

Optimistic Vaccine Activist: Embracing Hope for the Future

The United States is facing an uncertain future when it comes to vaccine policy. With potential appointees like Robert F. Kennedy Jr., Mehmet Oz,...
news-22112024-082138

Pfizer’s New R&D Head, VC Deep-Dive, and FDA Commissioner: What You Need to Know

Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally,...
news-22112024-082107

FAQs: Understanding IGAs in Animals

Intentional Genomic Alterations (IGAs) in animals refer to changes made to an animal's DNA using modern molecular technologies. These alterations can include targeted DNA...
news-21112024-183110

Novartis Acquires Kate Therapeutics to Advance Muscular Dystrophy Treatment

Novartis made a significant move in the field of gene therapy by acquiring Kate Therapeutics for up to $1.1 billion. This acquisition includes not...
news-21112024-122547

Kura Oncology Licenses Leukemia Drug to Japanese Drugmaker

Kura Oncology and the Japanese drugmaker Kyowa Kirin have joined forces in a global partnership to work on Kura’s new treatment for acute leukemia....
news-21112024-062439

Medicaid Official Criticizes Republican Reform as Poor Policy

Medicaid, a program that provides health coverage to millions of low-income Americans, is facing potential cuts as Republicans look to fund tax cuts and...
news-20112024-122223

Apellis Triumphs while Astellas Faces Defeat

Good morning! Today, there is a lot of news from the American Heart Association's annual meeting, and former National Cancer Institute chief Ned Sharpless...

BREAKING NEWS

Top News